KRT19 and cholangiocarcinoma: Lastly, CK19 is expressed in liver tumors other than HCC (e.g., cholangiocarcinoma, combined cholangiocarcinoma–HCC, and hepatoid adenocarcinoma); whether our classifier can accurately differentiate CK19+ HCC from these tumors remains to be determined.